The burgeoning popularity of Semaglutide for size reduction has sparked considerable interest both within the medical realm and among the general population. Initially approved for treating type 2 diabetes, its remarkable tendency to promote noticeable weight management has led to its off-label application by many. Clinical trials have demonstrated